Brain Attack and Cerebrovascular Disease 2024

Brain Attack and Cerebrovascular Disease 2024 is organized by Columbia University Vagelos College of Physicians and Surgeons (VP&S) and will be held on Oct 25, 2024 at Weill Cornell Medical Center, New York, United States of America.

Description:
The Brain Attack course is a yearly comprehensive review of the field of cerebrovascular disease. It covers epidemiology, diagnosis, acute management, secondary prevention, and rehabilitation. The audience includes physicians and also nurses and emergency medicine services personnel from the tri-state area as well as nationally. The course is held yearly with a series of core topics focusing on acute stroke management and is supplemented by new lectures each year to cover advances in the field.

The faculty for the course includes stroke specialists from the Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine as well as faculty from the departments of radiology, neurosurgery, emergency medicine, and rehabilitation medicine, and expert guest faculty from outside our institution. A multidisciplinary team provides a broad-spectrum curriculum and a practical approach to the cerebrovascular field. The Brain Attack Course ?fulfills the 8-hour annual CME/CH requirement for Stroke Centers as per the New York State Department of Health and certifying organizations such as The Joint Commission. The course will also include 1 hour of Call Review with CME accreditation.

Educational objectives:
• At the conclusion of this activity, participants will be better able to:
• Recognize modern advances in the diagnosis and management of small vessel cerebrovascular disease.
• Examine the epidemiology, pathophysiology, and optimal diagnostic studies and treatments for stroke in young patients.
• Analyze recent advances for the treatment of cerebral veinous thrombosis with a focus on direct oral anticoagulants and endovascular therapies.
• Describe different acute treatment options for patients with minor ischemic stroke, particularly dual antiplatelet therapy and intravenous thrombolysis.
• Discuss the various evidence-based treatment options for the management of ischemic stroke due to intracranial atherosclerosis.